Cholesterol modulates the membrane effects and spatial organization of membrane-penetrating ligands for G-protein coupled receptors.
The ligands of certain G-protein coupled receptors (GPCRs) are membrane soluble and reach their target from the lipid bilayer. Lipid composition and dynamics will therefore modulate the activity of these receptors, but specific roles of lipid components, including the ubiquitous cholesterol (Chol), are not clear. We have probed the organization and dynamics of such a lipid-bilayer-penetrating ligand, the endogenous ligand for the κ-opioid receptor (KOR) dynorphin A (1-17) (DynA), using molecular dynamics (MD) simulations of DynA in cholesterol-depleted and cholesterol-enriched model membranes. DynA is found to penetrate deep inside fluid dimyristoylphosphatidylcholine (DMPC) bilayers, and resides with its N-terminal helix at ∼6 Å away from the bilayer midplane, in a tilted orientation, at an ∼50° angle with respect to the membrane normal. In contrast, DynA inside DMPC/Chol membranes with 20% cholesterol (DMPC/Chol) is situated with its helical segment ∼5 A higher, i.e., closer to the lipid/water interface and in a relatively vertical orientation. The DMPC membrane shows greater thinning around the insertion and permits a stronger influx of water inside the hydrocarbon core than the DMPC/Chol membranes. Relating these results to data about key GPCR residues that have been implicated in interactions with membrane-inserting GPCR ligands, we conclude that the position of DynA in DMPC/Chol, but not in pure DMPC, correlates with generally proposed GPCR ligand entry pathways. Our predictions provide a possible mechanistic explanation as to why DynA binding to KOR, and the subsequent activation of the receptor, is facilitated in cholesterol-enriched environments. A quantitative description of DynA-induced membrane deformations is obtained with a continuum theory of membrane deformations (CTMD) that is based on hydrophobic matching. Comparison with the MD data reveals the significance of the lipid tail packing energy contribution in the DMPC/Chol mixtures in predicting equilibrium membrane shape around DynA. On this basis, specific corrections are introduced to this energy term within the CTMD framework, thereby extending the applicability of the CTMD framework to lipid raft mixtures and their interactions with GPCR proteins and their ligands.
Khelashvili
George
G
Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, New York, USA. gek2009@med.cornell.edu
Mondal
Sayan
S
Andersen
Olaf S
OS
Weinstein
Harel
H
D000595:Amino Acid Sequence; D002462:Cell Membrane / Q000737:chemistry / Q000378:metabolism*; D002784:Cholesterol / Q000737:chemistry / Q000378:metabolism*; D004134:Dimyristoylphosphatidylcholine / Q000737:chemistry / Q000378:metabolism; D004399:Dynorphins / Q000737:chemistry; D057927:Hydrophobic and Hydrophilic Interactions; D008024:Ligands; D008051:Lipid Bilayers / Q000737:chemistry / Q000378:metabolism; D021962:Membrane Microdomains / Q000737:chemistry / Q000378:metabolism; D008968:Molecular Conformation; D056004:Molecular Dynamics Simulation; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*; D017473:Receptors, Opioid, kappa / Q000378:metabolism; D014867:Water / Q000378:metabolism
D008024:Ligands; D008051:Lipid Bilayers; D010446:Peptide Fragments; D043562:Receptors, G-Protein-Coupled; D017473:Receptors, Opioid, kappa; D014867:Water; D004399:Dynorphins; D002784:Cholesterol; D004134:Dimyristoylphosphatidylcholine
Biophys J. 2003 Mar;84(3):2080-9
12609909
Biophys J. 2000 Nov;79(5):2583-604
11053132
Adv Protein Chem. 2003;63:243-90
12629973
Biochim Biophys Acta. 2006 Sep;1758(9):1292-302
16542637
Phys Rev Lett. 1990 Apr 23;64(17):2094-2097
10041575
Biochim Biophys Acta. 2007 Apr;1768(4):794-807
17188232
J Comput Aided Mol Des. 2006 Feb;20(2):97-107
16783601
J Phys Chem B. 2010 Jun 10;114(22):7524-34
20518573
Biophys J. 2010 Jul 7;99(1):175-83
20655845
Curr Opin Drug Discov Devel. 2005 Sep;8(5):577-84
16159019
Prog Lipid Res. 2006 Jul;45(4):295-333
16616960
Biophys J. 2001 Apr;80(4):1649-58
11259280
Biophys J. 2008 Nov 1;95(9):4324-36
18658211
Biochemistry. 1997 Feb 25;36(8):1971-81
9047294
J Am Chem Soc. 2002 Jan 16;124(2):318-26
11782184
Chem Phys Lipids. 2006 Sep;143(1-2):1-10
16737691
J Biol Chem. 2005 Apr 1;280(13):12212-20
15657045
Nature. 2008 Jul 10;454(7201):183-7
18563085
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3654-8
19225105
Biophys J. 2010 Jan 20;98(2):248-57
20338846
Biophys J. 1999 Jan;76(1 Pt 1):351-9
9876147
Biopolymers. 1991 May;31(6):785-92
1657234
Annu Rev Biophys Biomol Struct. 2004;33:269-95
15139814
Proteins. 2009 Aug 1;76(2):403-17
19173312
Biophys J. 2001 Aug;81(2):643-58
11463613
Biophys J. 2007 Jun 1;92(11):3960-7
17369407
Biophys J. 2000 Mar;78(3):1376-89
10692323
Trends Biochem Sci. 2005 Aug;30(8):430-6
15996869
Cell Mol Life Sci. 2000 Oct;57(11):1577-92
11092453
Chem Biol. 2008 Nov 24;15(11):1207-19
19022181
Biochim Biophys Acta. 1995 Sep 13;1238(2):163-76
7548131
Biophys J. 1998 Apr;74(4):1966-83
9545056
J Lipid Res. 2003 Apr;44(4):655-67
12562849
Phys Rev Lett. 2008 May 16;100(19):198103
18518492
Biophys J. 1998 Sep;75(3):1372-83
9726938
Biophys J. 2000 Nov;79(5):2331-44
11053113
Biophys J. 1999 Jul;77(1):3-22
10388736
Biophys J. 1997 Jul;73(1):267-76
9199791
Biochim Biophys Acta. 2009 Jan;1788(1):97-121
18823938
Nat Rev Mol Cell Biol. 2006 Jan;7(1):9-19
16365634
J Comput Chem. 2005 Dec;26(16):1781-802
16222654
J Phys Chem B. 1998 Apr 30;102(18):3586-616
24889800
Annu Rev Biophys Biomol Struct. 2003;32:257-83
12543707
Nature. 1998 Aug 20;394(6695):798-801
9723621
Cell. 2003 Nov 14;115(4):377-88
14622593
Biochemistry. 2004 Dec 14;43(49):15318-28
15581344
J Phys Chem B. 2005 Mar 24;109(11):5300-11
16863197
Biochim Biophys Acta. 2008 Jun;1778(6):1460-6
18358828
Methods Enzymol. 2002;343:329-71
11665578
Biochim Biophys Acta. 2005 Dec 30;1746(3):172-85
16043244
Physiology (Bethesda). 2006 Dec;21:430-9
17119156
Biochim Biophys Acta. 1978 Oct 19;513(1):43-58
718889
Annu Rev Biophys Biomol Struct. 2007;36:107-30
17263662
Biophys J. 2009 Jul 8;97(1):50-8
19580743
J Biol Chem. 2010 Jun 4;285(23):17954-64
20220143
Nature. 1998 Aug 20;394(6695):802-5
9723622
J Lipid Res. 1998 May;39(5):947-56
9610760
Biophys J. 2008 May 15;94(10):3935-44
18234811
Biopolymers. 1995;37(1):5-16
7880967
Z Naturforsch C. 1973 Nov-Dec;28(11):693-703
4273690
J Phys Chem B. 2006 Dec 28;110(51):25562-4
17181184
Eur Biophys J. 2003 Feb;31(8):575-85
12582817
J Med Chem. 1997 Sep 26;40(20):3254-62
9379445
Biochemistry. 1990 Nov 27;29(47):10676-84
2271675
Biophys Chem. 2004 Feb 1;107(2):151-64
14962596
Pharmacol Ther. 2004 Jul;103(1):21-80
15251227
Colloids Surf B Biointerfaces. 2004 Oct 10;38(1-2):11-4
15465298
Biophys J. 2009 Sep 16;97(6):1626-35
19751667
Biopolymers. 1983 Dec;22(12):2577-637
6667333
PLoS One. 2009;4(2):e4382
19194506
J Pharmacol Exp Ther. 2006 Jun;317(3):1295-306
16505160
Biophys J. 2006 Apr 1;90(7):2368-82
16399829
J Biol Chem. 1989 May 15;264(14):8151-5
2722776
Biochim Biophys Acta. 1979 Oct 19;557(1):259-63
549641
Science. 2010 Jan 1;327(5961):46-50
20044567
J Chem Phys. 2004 May 22;120(20):9841-7
15268001
Biochim Biophys Acta. 2007 Oct;1768(10):2586-95
17662236
Trends Pharmacol Sci. 2007 Aug;28(8):397-406
17629961
Biochemistry. 1992 Jul 28;31(29):6739-47
1637810
J Mol Endocrinol. 2004 Apr;32(2):325-38
15072542
Biophys J. 2002 Aug;83(2):1004-13
12124282
Biochemistry. 1988 Jun 28;27(13):4668-73
3167010
Nature. 1997 Jun 5;387(6633):569-72
9177342
AAPS J. 2006 Jan 06;7(4):E871-84
16594640